Healthcare provider profile · identity verified

Barbara Spivak, MD

Internal Medicine · WATERTOWN, MA · NPI 1952301251

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	395	106
Lisinopril	Lisinopril	318	80
Amlodipine Besylate	Amlodipine Besylate	255	66
Simvastatin	Simvastatin	204	55
Lorazepam	Lorazepam	203	39
Metoprolol Succinate	Metoprolol Succinate	203	54
Gabapentin	Gabapentin	187	34
Levothyroxine Sodium	Levothyroxine Sodium	177	49
Losartan Potassium	Losartan Potassium	127	25
Eliquis	Apixaban	123	24
Metformin Hcl	Metformin Hcl	120	37
Omeprazole	Omeprazole	112	34
Citalopram Hbr	Citalopram Hydrobromide	111	24
Trazodone Hcl	Trazodone Hcl	99	21
Rosuvastatin Calcium	Rosuvastatin Calcium	78	21
Atenolol	Atenolol	76	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	76	20
Tramadol Hcl	Tramadol Hcl	70	12
Albuterol Sulfate Hfa	Albuterol Sulfate	68	19
Sertraline Hcl	Sertraline Hcl	65	17
Alendronate Sodium	Alendronate Sodium	63	17
Hydrochlorothiazide	Hydrochlorothiazide	58	18
Allopurinol	Allopurinol	45	13
Famotidine	Famotidine	45	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	suppressed
Mirtazapine	Mirtazapine	45	13
Clopidogrel	Clopidogrel Bisulfate	43	suppressed
Furosemide	Furosemide	42	15
Chlorthalidone	Chlorthalidone	41	11
Synthroid	Levothyroxine Sodium	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	15
Pantoprazole Sodium	Pantoprazole Sodium	39	12
Prednisone	Prednisone	39	suppressed
Clonazepam	Clonazepam	34	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	suppressed
Alprazolam	Alprazolam	26	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	26	suppressed
Estradiol	Estradiol	25	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	25	suppressed
Amoxicillin	Amoxicillin	23	12
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Raloxifene Hcl	Raloxifene Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Jardiance	Empagliflozin	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Ozempic	Semaglutide	18	suppressed
Carvedilol	Carvedilol	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Nystatin	Nystatin	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Torsemide	Torsemide	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Finasteride	Finasteride	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Potassium Chloride	Potassium Chloride	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Yuvafem	Estradiol	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Digoxin	Digoxin	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error